{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:18:03Z","timestamp":1786123083353,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03381-6","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:52:48Z","timestamp":1786110768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0456-022X","authenticated-orcid":false,"given":"Umama","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Umar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ansab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzaib","family":"Rafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonaira","family":"Mushahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhee","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaiza Naseer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Moiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazeela","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"9","key":"3381_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"PA Wolf","year":"1987","unstructured":"Wolf PA (1987) Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham study. Arch Intern Med 147(9):1561","journal-title":"Arch Intern Med"},{"issue":"2","key":"3381_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61(2):755\u2013759","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"3381_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K, Piayda K, Praco\u0144 R, Jackson GG et al (2021) Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. J Am Coll Cardiol 78(4):297\u2013313","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3381_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","volume":"45","author":"A Samaras","year":"2024","unstructured":"Samaras A, Papazoglou AS, Balomenakis C, Bekiaridou A, Moysidis DV, Patsiou V et al (2024) Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis. Eur Heart J 45(3):214\u2013229","journal-title":"Eur Heart J"},{"issue":"4","key":"3381_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","volume":"123","author":"VY Reddy","year":"2011","unstructured":"Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S (2011) Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 123(4):417\u2013424","journal-title":"Circulation"},{"issue":"18","key":"3381_CR6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","volume":"79","author":"JV Freeman","year":"2022","unstructured":"Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA et al (2022) Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation. J Am Coll Cardiol 79(18):1785\u20131798","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"3381_CR7","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","volume":"16","author":"M Coylewright","year":"2023","unstructured":"Coylewright M, Holmes DR, Kapadia SR, Hsu JC, Gibson DN, Freeman JV et al (2023) DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. JACC Cardiovasc Interv 16(22):2708\u20132718","journal-title":"JACC Cardiovasc Interv"},{"issue":"31","key":"3381_CR8","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","volume":"37","author":"LVA Boersma","year":"2016","unstructured":"Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E et al (2016) Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 37(31):2465\u20132474","journal-title":"Eur Heart J"},{"issue":"14","key":"3381_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S et al (2018) Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 71(14):1528\u20131536","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3381_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN et al (2018) Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation 138(9):874\u2013885","journal-title":"Circulation"},{"issue":"4","key":"3381_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.hrthm.2024.11.035","volume":"22","author":"NA Lima","year":"2025","unstructured":"Lima NA, Filho FWPA, Mendes BX, Neto VLM, d\u2019Avila ALB (2025) Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 22(4):979\u2013986","journal-title":"Heart Rhythm"},{"key":"3381_CR12","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions (current version) | Cochrane [Internet]. 2025 Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"key":"3381_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3381_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"3381_CR15","unstructured":"Newcastle-Ottawa Scale (NOS) | Ottawa Hospital Research Institute [Internet]. 2026 Available from: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"issue":"7109","key":"3381_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"key":"3381_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2021.02.054","volume":"333","author":"L Faroux","year":"2021","unstructured":"Faroux L, Cruz-Gonz\u00e1lez I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V et al (2021) Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy. Int J Cardiol 333:77\u201382","journal-title":"Int J Cardiol"},{"issue":"11","key":"3381_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8110142","volume":"8","author":"PL Cepas-Guillen","year":"2021","unstructured":"Cepas-Guillen PL, Flores-Umanzor E, Regueiro A, Brugaletta S, Iba\u00f1ez C, Sanchis L et al (2021) Low dose of direct oral anticoagulants after left atrial appendage occlusion. J Cardiovasc Dev Dis 8(11):142","journal-title":"J Cardiovasc Dev Dis"},{"issue":"21","key":"3381_CR19","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","volume":"14","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG, Magnocavallo M, Di Biase L, Mohanty S, Trivedi C, Tarantino N et al (2021) Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion. JACC Cardiovasc Interv 14(21):2353\u20132364","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"3381_CR20","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2411335","volume":"24","author":"X Li","year":"2023","unstructured":"Li X, Jin Q, Yao Y, Zhang X, Lv Q (2023) Clinical effectiveness and safety comparison between reduced rivaroxaban dose and dual antiplatelet therapy for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure: a prospective observational study. Rev Cardiovasc Med 24(11):335","journal-title":"Rev Cardiovasc Med"},{"issue":"10","key":"3381_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","volume":"9","author":"X Freixa","year":"2024","unstructured":"Freixa X, Cruz-Gonz\u00e1lez I, Cepas-Guill\u00e9n P, Mill\u00e1n X, Ant\u00fanez-Mui\u00f1os P, Flores-Umanzor E et al (2024) Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial. JAMA Cardiol 9(10):922","journal-title":"JAMA Cardiol"},{"issue":"25","key":"3381_CR22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/CIRCULATIONAHA.125.077469","volume":"152","author":"J Rod\u00e9s-Cabau","year":"2025","unstructured":"Rod\u00e9s-Cabau J, Nombela-Franco L, Cruz-Gonzalez I, Hibbert B, Freixa X, Masson JB et al (2025) Short-Term Anticoagulation Versus DASual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial. Circulation 152(25):1759\u20131768","journal-title":"Circulation"},{"issue":"7","key":"3381_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","volume":"13","author":"G Duthoit","year":"2020","unstructured":"Duthoit G, Silvain J, Marijon E, Ducrocq G, Lepillier A, Frere C et al (2020) Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study. Circ Cardiovasc Interv 13(7):e008481","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"3381_CR24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","volume":"4","author":"M Alkhouli","year":"2018","unstructured":"Alkhouli M, Busu T, Shah K, Osman M, Alqahtani F, Raybuck B (2018) Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion. JACC Clin Electrophysiol 4(12):1629\u20131637","journal-title":"JACC Clin Electrophysiol"},{"key":"3381_CR25","doi-asserted-by":"publisher","unstructured":"Sedaghat A, Nickenig G, Schrickel JW, Ince H, Schmidt B, Protopopov AV, et al. Incidence, predictors and outcomes of device\u2010related thrombus after left atrial appendage closure with the WATCHMAN device\u2014Insights from the EWOLUTION real world registry. Catheter Cardiovasc Interv (2021) (2026);97(7). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/ccd.29458","DOI":"10.1002\/ccd.29458"},{"key":"3381_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69979","author":"G Tabowei","year":"2024","unstructured":"Tabowei G, Rawat A, Alreshidi FS, Ayyub Kantharia F, Hanif L, Alghzawi HM et al (2024) Efficacy and safety of low or reduced dose direct oral anticoagulants versus dual antiplatelet therapy following left atrial appendage closure: a systematic review and meta-analysis. Cureus. https:\/\/doi.org\/10.7759\/cureus.69979","journal-title":"Cureus"},{"issue":"18","key":"3381_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185955","volume":"12","author":"F Luc\u00e0","year":"2023","unstructured":"Luc\u00e0 F, Oliva F, Abrignani MG, Di Fusco SA, Parrini I, Canale ML et al (2023) Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios. J Clin Med 12(18):5955","journal-title":"J Clin Med"},{"issue":"1","key":"3381_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/dj4010005","volume":"4","author":"H Schwarb","year":"2016","unstructured":"Schwarb H, Tsakiris D (2016) New direct oral anticoagulants (DOAC) and their use today. Dent J 4(1):5","journal-title":"Dent J"},{"issue":"2","key":"3381_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/rth2.12080","volume":"2","author":"RH Olie","year":"2018","unstructured":"Olie RH, Van Der Meijden PEJ, Ten Cate H (2018) The coagulation system in atherothrombosis: implications for new therapeutic strategies. Res Pract Thromb Haemost 2(2):188\u2013198","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"3381_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11239-023-02919-2","volume":"57","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Liu X, Gu ZC, Yang X, Huang X, Wu Y et al (2024) Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis. J Thromb Thrombolysis 57(2):194\u2013203","journal-title":"J Thromb Thrombolysis"},{"key":"3381_CR31","doi-asserted-by":"publisher","unstructured":"Samaras A, Karakasis P, Feidakis A, Giannakoulas G, Fragakis N, Nielsen-Kudsk J-E, et al. Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis. Eur Heart J Cardiovasc Pharmacother [Internet]. 2026;12(1):38\u201351. Available from: https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf078","DOI":"10.1093\/ehjcvp\/pvaf078"},{"issue":"18","key":"3381_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","volume":"82","author":"P Carvalho","year":"2023","unstructured":"Carvalho P, Gewehr D, Miyawaki I et al (2023) Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion. J Am Coll Cardiol 82(18):1765\u20131773. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.010","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03381-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03381-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03381-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:52:50Z","timestamp":1786110770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03381-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":32,"alternative-id":["3381"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03381-6","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a review.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}